genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
Base editing
Drug Discovery
Cloaking Device: Liu, Joung Launch $100M Nvelop Therapeutics to Advance Delivery of Genetic Cargo
Cancer
Precise Cell Engineering Using Base Editing Demonstrated by Single-Cell Multiomics
Drug Discovery
Base Editing Strategy for Spinal Muscular Atrophy Rescues Patient Fibroblasts, Reverses Mouse Pathology
Genome Editing
Base Editing Corrects Autism Variant in Mouse Brain
Genome Editing
“Transformer” Base Editor Safely and Durably Induces Fetal Hemoglobin in Human HSCs
GEN Edge
StockWatch: Verve Investors Accentuate the Negative as Shares Tumble, Then Recover
Drug Discovery
StockWatch: Lilly-Beam Deal for Verve Base Editing Therapies Wows Analysts
GEN Edge
At Chardan Conference, David Liu Foresees First Prime Editing Clinical Trial in 2024
Genome Editing
Genotoxic Effects by Base and Prime Editors in Human HSPCs Aren’t Surprising, Says Pioneer
Cancer
Base Editing Tweaks HSC Epitopes for Targeted Immunotherapy
1
2
Page 1 of 2
Scroll Up